Publication | Open Access

Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial

Metabolic SyndromeUrologyRenal FunctionKidney FailureChronic Kidney DiseaseDiabetesClinical TrialsAsymptomatic HyperuricemiaGfr DeclinePlacebo-controlled TrialMedicineNephrologyHealth Sciences